Silencing cancer

Scientist

Volumn 18, Issue 17, 2004, Pages 14-15

  Lucentini, Jack ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; IMATINIB; RNA;

ANGIOGENESIS; BIOTECHNOLOGICAL PROCEDURES; CANCER CONTROL; CANCER RESISTANCE; DRUG DELIVERY SYSTEM; EXPRESSION VECTOR; GENE FUSION; GENE SILENCING; LEUKEMIA; MULTIDRUG RESISTANCE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; RETINA MACULA DEGENERATION; SHORT SURVEY;

VECTORS;

EID: 4844225005     PISSN: 08903670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. J. Downward, "RNA interference," Brit Med J, 328:1245-8, May 22, 2004.
2. E. Yague et al., "Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1E," Gene Ther, 11:1170-4, July 2004.
3. J. Chen et al., "Stable expression of small interfering RNA sensitizes TEL-PDGFβR to inhibition with imatinib or rapamycin," J Clin Invest, 113:1784-91, June 2004.
4. H. Kawasaki, K. Taira, "Induction of DNA methylation and gene silencing by short interfering RNAs in human cells," E-pub ahead of print, Nature, doi:10.1038/nature02889, Aug. 15, 2004.
5. H. Xia et al., "RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia," Nat Med, 10:816-20, August 2004.